bsi

Bloodstream infections: How do you proceed? Case-vignette based ESGAP/ESGBIS survey

ESGAP (the ESCMID Study Group for Antibiotic Policies) and ESGBIS (the ESCMID Study Group for Bloodstream Infections and Sepsis) are launching the ESGAP/ESGBIS Bloodstream infection survey, and we would be … Continue Reading →


ESGAP and the European Antibiotic Awareness Day

On the occasion of ECDC’s European Antibiotic Awareness Day and WHO’s Antibiotic Awareness Week ESGAP and EUCIC are releasing a special Newsletter (see here). A number of activities organised by … Continue Reading →


muria-logo

ESGAP meets MURIA. Are you gonna join?

By Jeroen Schouten (ESGAP EC member)   MURIA stands for Medicines Utilisation Research in Africa. MURIA grew out of discussions during the World Congress of Pharmacology and Clinical Pharmacology in … Continue Reading →


logo-7sec1

Antimicrobial Stewardship at the 7th Southeast European Conference on Chemotherapy an Infection

ESGAP was represented at the 7th Southeast European Conference on Chemotherapy and Infection (SEEC), held in Sibiu, Romania on 13-15 October 2016.   ESGAP organized a session on new antibiotics … Continue Reading →


united_nations_flag

Antimicrobial resistance at the highest political level: the beginning of the end or the end of the beginning?

By Bojana Beovic Antimicrobial resistance was discussed at the United Nations General Assembly (#UNGA) held on September 21, 2016. For the first time the leaders of 193 Member States agreed for a … Continue Reading →


flag_yellow_low

EU report on the implementation of the (2001) recommendation on the prudent use of antibiotics

The European Commission relased a report (download report here) on the implementation of the Council recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine. This … Continue Reading →


'Sorry, we're shorthanded - please pass over the scalpel...'

Is your Infectious Disease or Clinical Micro Service Understaffed? Have a look

By Bojana Beovic Infectious diseases and clinical microbiology specialties have undergone extreme changes in its scope in the last decades. Starting with HIV epidemics, these changes are far from and … Continue Reading →


'I thought we were going to IMPROVISE!'

Ten key points for the appropriate use of antibiotics in hospitalized patients

While celebrating the top-performing year among the different study groups of the ESCMID at the last ECCMID, the ESGAP executive committee was also receiving and discussing proposals for international collaborations … Continue Reading →


65837_7556

ESGAP and SPILF survey on duration of antimicrobial therapy is open

  ESGAP (the ESCMID Study Group for Antibiotic Policies) and SPILF (the French ID society) are launching the AB-Duration survey. Duration of antibiotic therapy is a not completely solved issue for many … Continue Reading →


Transparency

Do your patients know your local antibiotic resistance rates?

By Oliver Dyar Public Health England have recently made local data publicly available on five important topics: antimicrobial resistance antibiotic prescribing healthcare associated infections infection prevention and control and antibiotic … Continue Reading →